Abstract Background Gouty arthritis is a common metabolic disease caused by long-term purine metabolic disorder and elevated serum uric acid. Jiang-Suan-Chu-Bi recipe (JSCBR), a traditional Chinese herbal formula prescribed according to utilization frequency and cluster analysis, has been clinically validated remedy for gouty arthritis. However, its therapeutic composition and mechanism remains unclear. Methods In the present study, a simple, rapid, and sensitive ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS)-based chemical profiling was firstly established for comprehensively identifying the major constituents in JSCBR. A phytochemistry-based network pharmacology analysis was further performed to explore the potential therapeutic targets and pathways involved in JSCBR bioactivity. Finally, THP-1 cell model was used to verify the prediction results of network pharmacology by western blot analysis. Results A total of 139 compounds containing phenolic acids, flavonoids, triterpenoid saponins, alkaloids, amino acids, fatty acids, anthraquinones, terpenes, coumarins, and other miscellaneous compounds were identified, respectively. 175 disease genes, 51 potential target nodes, 80 compounds, and 11 related pathways based on network pharmacology analysis were achieved. Among these pathways and genes, NOD-like receptor signaling pathway may play an important role in the curative effect of JSCBR on gouty arthritis by regulation of NRLP3/ASC/CASP1/IL1B. The results of cellular and molecular experiments showed that JSCBR can effectively reduce the protein expression of ASC, caspase-1, IL-1β, and NRLP3 in monosodium urate-induced THP-1 cells, which indicated that JSCBR mediated inflammation in gouty arthritis by inhibiting the activation of NOD-like receptor signaling pathway. Conclusion Thus, the integrated approaches adopted in the present study could contribute to simplifying the complex system and providing directions for further research of JSCBR. Keywords: Jiang-Suan-Chu-Bi recipe (JSCBR), gouty arthritis, chemical profile, network pharmacology, NOD-like receptor signaling pathway Introduction Gouty arthritis is a metabolic disease caused by the deposition of monosodium urate crystals in joints and soft tissues ([39]Pascart et al., 2018) and closely associated with chronic hyperuricemia, which seriously affects quality of life of patients due to severe pain ([40]Nielsen et al., 2018). Across the globe, the age of onset is getting younger and younger ([41]Zhou et al., 2014). It is estimated that the number of gout patients in China will exceed 100 million in 2020. Now, gout has become the second largest metabolic disease in China ([42]Wilson and Saseen, 2016). At present, western medicines including colchicine, allopurinol, benzbromarone, and febuxostat have been used as the conventional therapy method for gouty arthritis. Although their short-term effect on inhibiting uric acid production, promoting uric acid excretion, or analgesic effect is optimistic, the side effects such as skin mucosal injury, kidney and liver injury, digestive tract injury, as well as some potential neurotoxicity and muscular toxicity caused by long-term use could not be ignored. Meanwhile, as the main form of traditional Chinese medicine (TCM) that based on the compatibility theory, traditional Chinese herbal formula has been applied for the treatment of gouty arthritis for thousands of years in view of remarkable therapeutic effect and little adverse reactions ([43]Zhou et al., 2014). Jiang-Suan-Chu-Bi recipe (JSCBR) is a formula prescribed according to utilization frequency and cluster analysis by retrieving gout-related data obtained from multiple databases ([44]Xiao et al., 2019), which has been clinically validated remedy for gouty arthritis under the guidance of TCM doctors. It consists of 12 herbs, namely, Smilax glabra Roxb. (tu-fu-ling in Chinese, TFL, batch No. 20160925), Paeonia lactiflora Pall (chi-shao in Chinese, CS, batch No. 20160814), Reynoutria japonica Houtt. (hu-zhang in Chinese, HZ, batch No. 20160728), Cremastra appendiculata (D.Don) Makino (shan-ci-gu in Chinese, SCG, batch No. 20160723), Rheum officinale Baill. (da-huang in Chinese, DH, batch No. 20160719), Clematis chinensis Osbeck (wei-ling-xian in Chinese, WLX, batch No. 20160915), Angelica pubescens Maxim. (du-huo in Chinese, Dh, batch No. 20160822), Phellodendron chinense C.K.Schneid. (huang-bai in Chinese, HB, batch No. 20160918), Atractylodes lancea (Thunb.) DC. (cang-zhu in Chinese, CZ, batch No. 20160814), Glycyrrhiza glabra L. (gan-cao in Chinese, GC, batch No. 20160816), Codonopsis pilosula (Franch.) Nannf. (dang-shen in Chinese, DS, batch No. 20160723), and Angelica sinensis (Oliv.) Diels (dang-gui in Chinese, DG, batch No. 20160801). Although its prescription is scientific and the efficacy is definite. To date, no reports on the chemical composition and functional mechanisms of JSCBR contribute to its bioactivity has been published, which restrict its further application and development. In the present study, a systematic dissection of JSCBR was employed by integrating chemical profile, network pharmacology, and experimental support using molecular cell biology. The schematic diagram of the present study was depicted in [45]Figure 1 . Figure 1. [46]Figure 1 [47]Open in a new tab The schematic diagram of the present study. Materials and Methods Chemicals, Reagents, and Materials UHPLC-MS grade acetonitrile and methanol were supplied by Merck Company Inc., (Darmstadt, Germany). MS grade formic acid was purchased from Fisher Scientific Company (Inc., Fairlawn, NJ). Ultrapure water (18.2 MΩ) was prepared with a Milli-Q water purification system (Millipore, Milford, MA, USA). All other reagents were of analytical grade and purchased from Tianjin Concord Technology Co. Ltd. (Tianjin, China). The reference compounds ferulic acid (56), polydatin (57), paeoniflorin (79), atractylodin (81), liquiritin (84), aloe-emodin (94), rhein (115), glycyrrhizic acid (119), osthole (126), columbianadin (127), and oleanolic acid (134) were purchased from Chengdu Pufei De Biotech (Chengdu, Sichuan, China). The reference compounds astilbin (60), chysophanol (93), physcion (100), and emodin (122) were purchased from Baoji Herbest Biotech (Baoji, Shanxi, China). The purity of each reference standard was determined to be over 98% by UHPLC analysis. All the 12 herbs of JSCBR were purchased from Beijing Tong-Ren-Tang Technologies Co., Ltd. (Taiyuan, Shanxi Province, China), and authenticated by Professor Yunpeng Diao (College of Pharmacy, Dalian Medical University). Voucher specimens were deposited at the authors’ laboratory. THP-1 cell was purchased from Yipu Biological Technology Co., Ltd. (Wuhan, Hubei Province, China). RPMI 1640 cell culture mediums and pencillin-streptomycin were purchased from Gibco BRL, Invitrogen Corporation (Grand Island, NY). Fetal bovine serum was purchased from Zhejiang Tianhang Biotechnology Co., Ltd. (Hangzhou, Zhejiang Province, China). Cell Counting Kit -8 (CCK-8) was purchased from Yiyuan Biotechnology Co., Ltd. (Guangzhou, Guangdong Province, China). Phorbol-12-myristate-13-acetate (PMA) was purchased from Abcam Ltd., (Cambridge, UK). Monosodium urate (MSU) was purchased from Sigma-Aldrich (St Louis, MO, USA). Colchicine was supplied by Shengshi Kangpu Chemical Technology Research Institute (Beijing, China). Antibodies against caspase-1, β-actin, apoptosis-associated speck-like protein (ASC), IL-1β, and antirabbit IgG-HRP were purchased from Bioss (Beijing, China). The BCA Protein Quantification Kit was purchased from KeyGen Biotech Co., Ltd. (Nanjing, Jiangsu Province, China). RIPA lysis buffer and PMSF protease inhibitor were purchased from Beyotime Institute of Technology (Shanghai, China). ECL-plus chemiluminescence reagent was purchased from Bio-rad (Richmond, CA, USA). Preparation of JSCBR Extract The usage of each crude herb were accurately weighed as follows: Smilacis Glabrae Rhizome (30 g), Paeoniae Radix Rubra (10 g), Polygoni Cuspidati Rhizoma et Radix (15 g), Cremastrae Pseudobulbus (8 g), Rhei Radix et Rhizoma (10 g), Clematidis Radix et Rhizome (15 g), Angelicae Pubescentis Radix (10 g), Phellodendri Chinensis Cortex (10 g), Atractylodis Rhizome (10 g), Glycyrrhizae Radix et Rhizome (10 g), Codonopsis Radix (15 g), and Angelicae Sinensis Radix (10 g). They were mixed and prepared by the decocting method as described below: a total of 153 g mixture was immersed in sevenfold mass of water for 2 h, heated and refluxed for 2 h and then filtered with six-layer absorbent gauze. A fivefold mass of water was subsequently added to the residues and boiled for 2 h. After being filtered with six-layer absorbent gauze, the two filters were combined and concentrated to 150 ml (equal to 1 g crude herb/ml). The liquid was finally transformed into powder by vacuum freeze drying technology. A 1.0 g of the freeze-dried powder was accurately weighted and extracted with 50 ml of methanol/water (1:1, v/v) for 30 min under ultrasound. The extract solution was centrifuged at 13,000 rpm for 10 min at 4°C and the supernatant was filtered through a 0.22 μm membrane filters. 1.0 μl of filtrate was injected to UHPLC-QTOF-MS for analysis. UHPLC-QTOF-MS Analysis The chromatography and MS conditions were almost the same as those reported in literature ([48]Huang et al., 2019). The only difference is the change of elution gradient, which was listed as follows: 0–25 min, 5%–45% B; 25–35 min, 45%–99% B; 35–38 min, 99%–5% B; 38–40 min, 5% B. Establishment of In-House Library for JSCBR and Generation of Empirical Molecular Formula The in-house library that covers all previous reported compounds from the 12 formulated herbs was established in a Microsoft office excel table, which includes compound name, molecular formula, molecular weight, chemical structures, natural source, and related references